Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T20:09:16.294Z.
Consensus retrieved: 2026-10-06T17:30:32.237Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T20:09:16.294Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 03e1a7bc6a4900f8947eb756f3a7beb4b36797f74791bf8fa7d12ffa125de730
Forward PE Ratio (N/A) = Dated Quote Price ($55.98) / Consensus Forward EPS ($-0.03)
FORWARD PE RATIO
N/A
Travere Therapeutics, Inc.
Market Cap
$5.21B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | $5.21B | N/A |
| Sotera Health Company (SHC)vs › | $5.20B | 18.53 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | N/A |
| Doximity, Inc. (DOCS)vs › | $5.20B | 20.63 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 50.13 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 19.75 |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 15.81 |
| Erasca, Inc. (ERAS)vs › | $4.96B | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $55.98, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.03 | $-0.06 – $0.04 | 7 | n/m |
| 2027-12-31 | $3.16 | $-0.21 – $6.30 | 8 | 17.7x |
| 2028-12-31 | $4.52 | $2.26 – $7.64 | 7 | 12.4x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
